We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Puts Forth PRIME Final Guidance on Drugs Addressing Unmet Medical Needs
EMA Puts Forth PRIME Final Guidance on Drugs Addressing Unmet Medical Needs
The European Medicines Agency (EMA) has issued a final guidance for drug developers on the quality data needed to support applications to its Priority Medicines (PRIME) program and other unmet medical need review pathways.